Epstein-Barr latent membrane protein 1 transformation site 2 activates NF-κB in the absence of NF-κB essential modifier residues 133–224 or 373–419
D Boehm, BE Gewurz, E Kieff… - Proceedings of the …, 2010 - National Acad Sciences
Epstein Barr virus latent membrane protein 1 (LMP1) induces NF-κB activation through
transformation effector sites (TES) 1 and 2, both of which are critical for B-lymphocyte …
transformation effector sites (TES) 1 and 2, both of which are critical for B-lymphocyte …
Epstein-Barr latent membrane protein 1 transformation site 2 activates NF-kappaB in the absence of NF-kappaB essential modifier residues 133-224 or 373-419.
D Boehm, BE Gewurz, E Kieff… - Proceedings of the …, 2010 - europepmc.org
Epstein Barr virus latent membrane protein 1 (LMP1) induces NF-κB activation through
transformation effector sites (TES) 1 and 2, both of which are critical for B-lymphocyte …
transformation effector sites (TES) 1 and 2, both of which are critical for B-lymphocyte …
Epstein–Barr latent membrane protein 1 transformation site 2 activates NF-κB in the absence of NF-κB essential modifier residues 133–224 or 373–419
D Boehm, BE Gewurz, E Kieff… - Proceedings of the …, 2010 - JSTOR
Epstein Barr virus latent membrane protein 1 (LMP1) induces NF-κB activation through
transformation effector sites (TES) 1 and 2, both of which are critical for B-lymphocyte …
transformation effector sites (TES) 1 and 2, both of which are critical for B-lymphocyte …
[PDF][PDF] Epstein–Barr latent membrane protein 1 transformation site 2 activates NF-κB in the absence of NF-κB essential modifier residues 133–224 or 373–419
D Boehm, BE Gewurz, E Kieff, E Cahir-McFarland - PNAS, 2010 - researchgate.net
Results LMP1 TES2-Mediated NF-κB Activation Requires NEMO. To determine whether
NEMO is required for LMP1 TES2-mediated NF-κB activation, we performed NF-κB …
NEMO is required for LMP1 TES2-mediated NF-κB activation, we performed NF-κB …
[HTML][HTML] Epstein-Barr latent membrane protein 1 transformation site 2 activates NF-κB in the absence of NF-κB essential modifier residues 133–224 or 373–419
D Boehm, BE Gewurz, E Kieff… - Proceedings of the …, 2010 - ncbi.nlm.nih.gov
Epstein Barr virus latent membrane protein 1 (LMP1) induces NF-κB activation through
transformation effector sites (TES) 1 and 2, both of which are critical for B-lymphocyte …
transformation effector sites (TES) 1 and 2, both of which are critical for B-lymphocyte …
Epstein-Barr latent membrane protein 1 transformation site 2 activates NF-kappaB in the absence of NF-kappaB essential modifier residues 133-224 or 373-419
D Boehm, BE Gewurz, E Kieff… - Proceedings of the …, 2010 - pubmed.ncbi.nlm.nih.gov
Epstein Barr virus latent membrane protein 1 (LMP1) induces NF-κB activation through
transformation effector sites (TES) 1 and 2, both of which are critical for B-lymphocyte …
transformation effector sites (TES) 1 and 2, both of which are critical for B-lymphocyte …
Epstein-Barr latent membrane protein 1 transformation site 2 activates NF-κB in the absence of NF-κB essential modifier residues 133-224 or 373-419
D Boehm, BE Gewurz, E Kieff… - Proceedings of the …, 2010 - ui.adsabs.harvard.edu
Epstein Barr virus latent membrane protein 1 (LMP1) induces NF-κB activation through
transformation effector sites (TES) 1 and 2, both of which are critical for B-lymphocyte …
transformation effector sites (TES) 1 and 2, both of which are critical for B-lymphocyte …
Epstein-Barr latent membrane protein 1 transformation site 2 activates NF-kappaB in the absence of NF-kappaB essential modifier residues 133-224 or 373-419.
D Boehm, BE Gewurz, E Kieff… - Proceedings of the …, 2010 - europepmc.org
Epstein Barr virus latent membrane protein 1 (LMP1) induces NF-κB activation through
transformation effector sites (TES) 1 and 2, both of which are critical for B-lymphocyte …
transformation effector sites (TES) 1 and 2, both of which are critical for B-lymphocyte …